POLE and cancer: We found that mutation rates of contexts subject to localized mutational processes (UV-signature 7a, POLE-signature 62, lymphoma-signature 72, and unknown etiology-signature 17b) were 4–9-fold increased compared to what can be explained by cancer type and mutational signature alone.